Sensulin Biotech, an Oklahoma startup, is bringing the lowest-cost Smart Insulin to the market. Mike Moradi, CEO of Sensulin and General Partner of Cortado Ventures, aims to reduce the burden of diabetes and change lives by creating innovative opportunities for their consumers. Discover how Sensulin revolutionizes diabetes management with their glucose-responsive insulin.
Recent Posts
- Sensulin: Introducing the Most Affordable Smart Insulin to the Market
- Myri Health featured in Journal Record – Selected for Google Accelerator
- Cortado Ventures Doubleshot Newsletter: April 2024
- Susan Moring Named “Rising Star” by National Venture Capital Association
- Empowering Women in Legacy Sectors: Celebrating Innovators in Manufacturing and Supply Chain